Tissue Regenix Share Chat (TRX)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Tissue Regenix	LSE:TRX	London	Ordinary Share	GB00B5SGVL29	ORD 0.5P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	+0.00p	+0.00%	11.00p	10.50p	11.50p	11.00p	11.00p	11.00p	0	07:37:46

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	1.4	-10.9	-1.3	-	83.61

Tissue Regenix Share Discussion Threads

Showing 8951 to 8973 of 8975 messages

Chat Pages: 359 358 357 356 355 354 353 352 351 350 349 348 Older

Date	Subject	Author	Discuss
26/7/2017 14:59	bamboo to be honest I don't have a clue, and would say that your knowledge in these matters is far superior than mine. See the share price still holding around 11p, but there is another 2 weeks to go before any new shares will be admitted to A.I.M. so plenty of time for the mm's to play around with the share price I'm sitting "on the fence" until then before I decide to add or not.	channel pirate	Read Full Thread Reply
26/7/2017 12:24	cp, Can the co can process Allografts and Xenografts in the same building? I think this is why in the UK there is a physical separation in that NHSBT make the Allografts in Speke, while Xenograft is made at HQ in Leeds. This may not be a problem when it comes to distribution etc. Not really sure.	bamboo2	Read Full Thread Reply
26/7/2017 07:18	bamboo, have the company said anything definite about xenographs not being a part of the future of the company other than there was a concern about 'shortage' of the products ? I did realise that the II's were investing pi's money, but the II's also have a reputation to protect, so again I assume a great deal of thought would have been applied before increasing the amount of money they invest into TRX. Again, with losing the roots of the company, then a great deal of thought will have been applied before changing direction, and one would assume it ultimately would be down to maintaining 'profit' as no profit - no company. You need to feel comfortable with where you have invested your hard earned money otherwise you will always have a nagging doubt. Reducing your exposure here may be something to consider before selling out completely - hedging your bet !! If only we all had a Chrystal Ball..............!!	channel pirate	Read Full Thread Reply
25/7/2017 20:35	cp, glad you were diversified then. Sill a big hit. TRX, I am concerned about the xenograft products. Without these we face a massive bottleneck in the production area. There is a worldwide shortage of all viable human derived transplant material other than skin. II's are investing other peoples money, and up to a point, individual investments that fail in small quantities are not a concern, amongst hundreds of others that do average or well. My concern is that we are losing our roots and the connection with the original idea of the co. This was the work done by Ingham and Fisher.	bamboo2	Read Full Thread Reply
25/7/2017 20:18	Bamboo, I was diversified then, but after entertaining the M.D.and his wife of CMR in my own home for a whole week-end where I so called learned a lot of what was supposedly going to happen in the next 6 months then the story sounded good. Coming back to TRX then if you think the share price will fall substantially from here it could be a good call to sell, BUT, the "big boys" have spent a lot of dosh............... Invesco Asset Management Limited acting as agent for its discretionary managed clients including the Invesco Funds ("IAML"), IP Group plc ("IP Group") and Woodford Investment Management Limited acting as agent for its discretionary managed clients ("Woodford") are related parties of the Company for the purposes of the AIM Rules by virtue of their status as substantial shareholders of the Company pursuant to the AIM Rules. Invesco Perpetual High Income Fund and Invesco Perpetual Income Fund (affiliates of IAML), IP2IPO Limited (an affiliate of IP Group) and Woodford have agreed to subscribe for 125,381,588, 50,000,000 and 139,000,000 New Ordinary Shares respectively as part of the Offer, conditional on Admission. Taking into account the related party transactions noted above, the Directors consider, having consulted with Jefferies, the Company's nominated adviser, that the terms of the Placing with such related parties are fair and reasonable in so far as its Shareholders are concerned................. so one would assume they think this to be a good investment. Time will tell, good luck with whatever decision you take.	channel pirate	Read Full Thread Reply
25/7/2017 17:46	cp, that's a lot to lose in one co. I hope you are diversified now! I am actively considering selling my TRX shares. I am disappointed that our products do not seem to have got more traction in the market. What could be better than a transplant that requires no anti-rejection medication? [assuming you need a transplant that is!] We know that the tech works. Stephan Badylak in the US has proven it time and again in many different animals and people. We have nearly 12 years of very good, long term results with TRX Heart Valves. Used in children with heart defects, this is the most challenging environment [due to the vigour of a childs immune system] for any graft, other than an auto-graft. Our Meniscus product is hailed as potentially the 'holy grail' of knee surgeons.	bamboo2	Read Full Thread Reply
24/7/2017 15:46	After loosing £250K in CMR, then I don't intend repeating it again. I have a self imposed limit (volume of shares) and I will not exceed it, but just hoping I can recover some of the CMR loss here.	channel pirate	Read Full Thread Reply
24/7/2017 15:29	cp, Please be very careful with it!	bamboo2	Read Full Thread Reply
24/7/2017 15:26	Either Way, the future looks bright if all goes to plan. Have a 1 year bond maturing tomorrow (25/07), cash in my bank account on Wednesday, so if we get down to around 10p, then I have another £18K to play with !!	channel pirate	Read Full Thread Reply
24/7/2017 15:15	cp, True. Big Co would also like some tax credits to offset the cost. On the other hand, management could get a taste for acquisitions!	bamboo2	Read Full Thread Reply
24/7/2017 15:07	Well, when the 2 companies are into 1, and generating a positive increasing income, that will make us an attractive target for one of the bigger players out there who might like to take us under their wing !!	channel pirate	Read Full Thread Reply
24/7/2017 14:53	On the positive side, at least management and staff will now have something to get their teeth into... lol	bamboo2	Read Full Thread Reply
24/7/2017 14:42	This t/o does completely change the complexion of the co, however, I am not sure what it does for the potential launch of xenografts in the US. Wonder if xenografts will end up being shelved?	bamboo2	Read Full Thread Reply
22/7/2017 07:04	bamboo2 Thanks for the link etc. Have just read through the letter from the Chairman and it sounds like the marriage of TRX and CellRight fit together well, making for an enlarged company that if all goes to plan will make us all very happy we hold shares here. Profitability by 2020, which is only two and a half years off, with rapid growth in the "light of day" as they say. Happy to hold and add a few more soon.	channel pirate	Read Full Thread Reply
21/7/2017 22:22	Bit of a roundabout route to find this on the co website. Country of origin to submit, and a few boxes to tick, etc :-/ Https://s3-eu-west-1.amazonaws.com/tissue-regenix/CellRight-Technologies-Acquisition-Circular.pdf	bamboo2	Read Full Thread Reply
21/7/2017 22:03	PUG, I am quite certain the share price was/is being maintained. Just looked that way for the past few weeks. IPO group had to get their own shenanigans out of the way before they could focus on this on maybe? Rayrac, the other shares you mention have something 'going' that imo is lacking here, for now. Not sure what it is, but I would think near or medium term potential holders would be best finding a comfortable seat somewhere 'at the back of the stand', out of the weather. Wait and see if the co can find some form. I still have a long term holding here, which for the first time in years is showing a loss. I'll continue to hold. I have a LOT of faith in Eileen Ingham and John Fisher at Leeds Uni.	bamboo2	Read Full Thread Reply
21/7/2017 15:08	PUGUGLY Have just taken the following info from the Companies Web-page Name of Shareholder % of Voting Rights Name of Shareholder: Invesco Limited % of Voting Rights: 27.75 Name of Shareholder: Woodford Investment Management LLP % of Voting Rights: 19.81 Name of Shareholder: Techtran Group Limited % of Voting Rights: 13.53 Name of Shareholder: Baillie Gifford & Co Ltd % of Voting Rights: 6.53 Name of Shareholder: University of Leeds % of Voting Rights: 4.39 Name of Shareholder: Jupiter Asset Management % of Voting Rights: 4.44 Name of Shareholder: NFU Mutual % of Voting Rights: 3.48 Name of Shareholder: John Samuel % of Voting Rights: 3.19	channel pirate	Read Full Thread Reply
21/7/2017 14:37	Ray, I think you still have more time to read and read again what Cellright have that interests TRX. Combine that with what TRX has already and see just what a big part of the market they will jointly cover. The mere fact that "Institutions only" have stomped up the best part of £40M in no time at all says to me hold on to what I have accumulated and maybe buy some more when the share price drops to / or below 10p. Looks like the Board have spent a few quid as well which is encouraging. As the old saying goes "if in doubt then stay out" could be applied, but will you miss a golden opportunity - only time will tell. Best of Luck whichever way you choose.	channel pirate	Read Full Thread Reply
21/7/2017 14:33	Rayrac - Just checked Does NOT seem to be a Woodford Holding in Patient Capital Please find the portfolio holdings as at 30 June 2017 below. (Unless I am blind !!) https://woodfordfunds.com/funds/wpct/portfolio/?chosenmonth=062017	pugugly	Read Full Thread Reply
21/7/2017 14:23	Hi PUGUGLY, something says Woodford is invested here, but I'm not 100% sure?	rayrac	Read Full Thread Reply
21/7/2017 14:17	Rayrac:- You could not have put it better - Many of Woodford's investments are off radar but some of the quoted ones such as Allied Minds and RM2 are very soggy - The fact he is invested here (I have not checked your point) makes it worth while looking but not jumping in without significant personal DD (imo)	pugugly	Read Full Thread Reply
21/7/2017 14:07	I kept thinking some other company would jump in for Cellright. But doesn't appear so. I've got mixed feelings about the deal. Have TRX been over generous in their offer? Have Cellright got products only of interest too TRX. When will the benefits come to boost the share price and is Woodford happy? I think about buying one minute, then reconsider. Got the cash, just need a good enough reason. I think I told bamboo that I was waiting for HUR to come good. Well it did to some extent, but I jumped out at a profit, then bought into the Weald oil basin, which has and is, doing spectacularly well. I realised some profit from there, but now I'm hesitant about spending it here. As you can see, I'm not into being a supporter of any particular segment of the market, I roam, looking for the best turns out there. But I have always been keen on biotechs etc and oils!	rayrac	Read Full Thread Reply
21/7/2017 10:42	the shares are at ta fraction of the placing price so pis could buy in the market- how people see the aquisitiona and the share price going forward	ali47fish	Read Full Thread Reply

Chat Pages: 359 358 357 356 355 354 353 352 351 350 349 348 Older